Cargando…
A highly expressed mRNA signature for predicting survival in patients with stage I/II non-small-cell lung cancer after operation
There is an urgent need to identify novel biomarkers that predict the prognosis of patients with NSCLC. In this study,we aim to find out mRNA signature closely related to the prognosis of NSCLC by new algorithm of bioinformatics. Identification of highly expressed mRNA in stage I/II patients with NS...
Autores principales: | Ma, Nan, Si, Lu, Yang, Meiling, Li, Meihua, He, Zhiyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955117/ https://www.ncbi.nlm.nih.gov/pubmed/33712694 http://dx.doi.org/10.1038/s41598-021-85246-x |
Ejemplares similares
-
5-mRNA-based prognostic signature of survival in lung adenocarcinoma
por: Xia, Qian-Lin, et al.
Publicado: (2023) -
A Gene Expression Signature Predicts Survival of Patients with Stage I Non-Small Cell Lung Cancer
por: Lu, Yan, et al.
Publicado: (2006) -
Matrix Metallopeptidase-Gene Signature Predicts Stage I Lung Adenocarcinoma Survival Outcomes
por: Liu, Chia-Hsin, et al.
Publicado: (2023) -
A 16-gene expression signature to distinguish stage I from stage II lung squamous carcinoma
por: Wang, Rui, et al.
Publicado: (2018) -
Combinatorial Blood Platelets-Derived circRNA and mRNA Signature for Early-Stage Lung Cancer Detection
por: D’Ambrosi, Silvia, et al.
Publicado: (2023)